JDRF aims to support studies that enhance beta cell health and function by limiting immune trafficking to the islets. The funding opportunity seeks to identify and validate strategies targeting islet homing pathways without broad immunosuppression. The goal is to accelerate the development of reagents promoting immune rebalance and beta cell protection through modulating immune cell trafficking to pancreatic islets. Grants of up to $900k over 3 years will be awarded. Deadlines:
